1 |
Thevenin, M.A., Grossiord, J.L., Poelman, M.C., 1996. Sucrose esters/co-surfactant ME systems for transdermal delivery: assessment of bicontinuous structures. Int. J. Pharm. 137, 177-186.
DOI
|
2 |
Zempsky W.T., Anand K.J.S., Sullivan, K.M., Fraser, D., Cucina, K., 1998. Lidocaine iontophoresis for topical anesthesia before intravenous line placement in children. J. Pediatrics. 132(6), 1061-1063.
DOI
|
3 |
Power, I., 2007. Fentanyl HCl iontophoretic transdermal system (ITS): clinical application of iontophoretic technology in the management of acute postoperative pain. Br. J. Anaesth. 98(1), 4-11.
DOI
|
4 |
Batheja, P., Thakur, R., Michniak, B., 2006. Transdermal iontophoresis. Expert Opin. Drug Deliv. 3(1), 127-138.
DOI
|
5 |
Ramachandran, C., Fleisher, D., 2000. Transdermal delivery of drugs for the treatment of bone diseases. Adv. Drug Deliver. Rev. 42, 197-223.
DOI
|
6 |
Reginster, J.Y., 1993. Calcitonin for prevention and treatment of osteoporosis. Am. J. Med. 95(5A), 44S-47S.
DOI
|
7 |
Sinha V.R., Maninder P.K., 2000. Permeation Enhancers for Transdermal Drug Delivery. Drug Dev. Ind. Pharm. 26(11), 1131-1140.
DOI
|
8 |
Sintov, A.C., Brandys-Sitton, R., 2006. Facilitated skin penetration of lidocaine: combination of a short-term iontophoresis and microemulsion formulation. Int. J. Pharm. 316(1-2), 58-67.
DOI
|
9 |
Subedi, R.K., Oh, S.Y., Chun, M.K., Choi, H.K., 2010. Recent advances in transdermal drug delivery. Arch. Pharm. Res. 33, 339-351.
DOI
|
10 |
Suh, H., Jun, H.W., 1996. Effectiveness and mode of action of isopropyl myristate as a permeation enhancer for naproxen through shed snake skin. J. Pharm. Pharmacol. 48, 812-816.
DOI
ScienceOn
|
11 |
Marcells, G.N., Ellis, D.A.F., 2000. Laser facial skin resurfacing: discussion on erbium:YAG and CO2 lasers. J. Otolaryngol. 29, 78–82.
|
12 |
Suwanpidokkul, N., Thongnopnua, P., Umprayn, K., 2004. Transdermal delivery of zidovudine (AZT): the effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin. AAPS PharmSciTech. 5(3), 48.
|
13 |
Tascioglu, F., Colak, O., Armagan, O., Alatas, O., Oner, C., 2005. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin. Rheumatol. Int. 26(1), 21-9.
DOI
|
14 |
Loftsson, T., Gildersleeve, N., Bodor, N., 1989. Effect of choline esters and oleic acid on the penetration of acyclovir, estradiol, hydrocortisone, nitroglycerin, retinoic acid and trifluorothymidine across hairless mouse skin in vitro. Acta. Pharm. Nord. 1, 279-286.
|
15 |
Matsuyama, T., Morita, T., Horikiri, Y., Yamahara, H., Yoshino, H., 2006. Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine as a mucolytic agent. J. Control. Rel. 115(2), 183-188.
DOI
|
16 |
Nair, V.B., Panchagnula, R., 2003. Effect of iontophoresis and fatty acids on permeation of arginine vasopressin through rat skin. Pharmacol. Res. 47(6), 563-569.
DOI
|
17 |
Nakamura K., Kazuya K., Mori K., Higo N., Sato S., Yamamoto K., 2001. Transdermal administration of salmon calcitonin by pulse depolarization-iontophoresis in rats. Int. J. Pharm. 218(1-2), 93-102.
DOI
|
18 |
Ongpipattanakul, B., Burnette, R.R., Potts, R.O., Francoeur, M.L., 1991. Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm. Res. 8(3), 350-354.
DOI
|
19 |
Pillai, O., Nair, V., Panchagnula, R., 2004. Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers. Int. J. Pharm. 269, 109-120.
DOI
|
20 |
Patel, S., Lyons, A.R., Hosking, D.J., 1993. Drugs used in the treatment of metabolic bone diseases. Drugs. 46, 594–617
|
21 |
Potts, R.O., Tamada, J.A., Tierny M.J., 2002. Glucose monitoring by reverse iontophoresis. Diabetes. Metab. Res. rev. 18(S1), S49-S63.
DOI
|
22 |
Ibrahim, S.A., Li, S.K., 2010. Chemical enhancer solubility in human stratum corneum lipids and enhancer mechanism of action on stratum corneum lipid domain. Int. J. Pharm. 383, 89-98.
DOI
|
23 |
Jacques, S.L., McAuliffe, D.J., Irvin, B.S., Blank, I.H., Parrish, J.A., 1987. Controlled removal of human stratum corneum by pulsed laser. J. Invest. Dermatol. 88, 88-93.
DOI
|
24 |
Jiang, S.J., Hwang, S.M., Choi, E.H., Elias, P.M., Ahn, S.K., Lee, S.H., 2000. Structural and functional effects of oleic acid and iontophoresis on hairless mouse stratum corneum. J. Invest. Dermatol. 114, 64-70.
DOI
|
25 |
Jung, S.A., Gwak, H.S., Chun, I.K., Oh, S.Y., 2008. Iontophoretic Delivery of Levodopa: Permeation Enhancement by Oleic Acid Microemulsion and Ethanol. J. Kor. Pharm. Sci. 38(6), 373-380.
|
26 |
Kigasawa, K., Kajimoto, K., Hama, S., Saito, A., Kanamura, K., Kogure, K., 2010. Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat. Int. J. Pharm. 383, 157-160.
DOI
|
27 |
Kreilgaard, M., 2002. Influence of microemulsions on cutaneous drug delivery. Adv. Drug Deliv. Rev. 54, S77-S98.
DOI
|
28 |
Lee, W.R., Shen, S.C., Wang, K.H., Hu, C.H., Fang, J.Y., 2002. The effect of Laser treatment on skin to enhance and control transdermal delivery of 5-flurouracil. J.Pharm. Sci. 91 (7), 1613-26.
DOI
|
29 |
Lamprecht A,, Yamamoto H., Takeuchi H., Kawashima Y., 2004. pH-sensitive microsphere delivery increases oral bioavailability of calcitonin. J. Control. Rel. 98(1), 1-9.
DOI
|
30 |
Leduc, S., 1908. Electric ions and their use in medicine. Rebman Ltd, London.
|
31 |
Chandra, A., Sharma, P.K., Irchhiaya, R., 2009. Microemulsionbased hydrogel formulation for transdermal delivery of dexamethasone. Asian. J. Pharmaceutics. 3(1), 30-36.
DOI
|
32 |
Delgado-Charro, M.B., Iglesias-Vilas, G., Blanco-Mendez, J., Lopez-Quintela, M.A., Marty, J.P., Guy, R.H., 1997. Delivery of a hydrophilic solute through the skin from novel microemulsion systems. Eur. J. Pharm. Biopharm. 43, 37-42.
DOI
|
33 |
Francoeur, M.L., Golden, G.M., Potts, R.O., 1990. Oleic acid: Its effects on stratum corneum in relation to (trans)dermal drug delivery. Pharm. Res. 7, 621- 627.
DOI
|
34 |
Ghanem, A.H., Mahmoud, H., Higuchi, W.I., Rohr, U.D., Borsadia, S., Liu, P., Fox, J., Good, W., 1987. The effects of ethanol on the transport of a-estradiol and other permeants in hairless mouse skin II. A New quantitative approach. J. Control. Rel. 6, 75-83.
DOI
|
35 |
Goodman M., Barry, B.W., 1988. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. J. Invest. Dermatol. 91, 323-327.
DOI
|
36 |
Bommannan, D., Potts, R.O., Guy, R.H., 1991. Examination of the effect of ethanol on human stratum corneum using infrared spectroscopy. J. Control. Rel. 16, 299-304.
DOI
|
37 |
Green, P.G., Hinz, R.S., Kim, A., Cullander C., Yamane G., Szoka Jr., F.C., Guy, R.H., 1992. Transdermal iontophoresis of amino acids and peptides in vitro, J. Control. Rel. 21(1-3), 187-190.
DOI
|
38 |
Heit, M.C., Riviere, J.E., 1997. Electrically-Assisted transdermal drug delivery. Pharm. Res. 14(6), 687-761.
DOI
|
39 |
Huwyler, R., Born, W., Ohanhaus, E.E., Fischer, J.A., 1979 Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man. Am. J. Physiol. 236, E15–E19
|
40 |
Bhatia, K.S., Gao, S., Singh. J., 1997. Effect of penetration enhancers and iontophoresis on the FT-IR spectroscopy and LHRH permeability. J. Control. Rel. 47, 81-89.
DOI
|